For too long, people living with rare diseases have faced uncertainty, delays, and unacceptable variation in the care they receive. The launch of this quality standard is a watershed moment. For the ...

The new NICE guidance recommends that most people should now be offered metformin along with an SGLT-2 inhibitor from the start, while also advising that they get a slow-release formulation of ...

A new editorial study on Gout, Urate, and Crystal Deposition Disease discusses the 2022 National Institute for Health and Care Excellence (NICE) guidelines for the management of gout. Study: Crystal ...

We support the implementation of guidelines by gathering system intelligence, understanding uptake, disseminating guidelines through networks, sharing actionable insight and best practice, and ...

New guidance from NICE recommends earlier use of SGLT-2 inhibitors and personalised treatment for people with type 2 diabetes ...

The National Institute for Health and Care Excellence (NICE) is a body which reviews latest evidence based on clinical trials, in order to provide robust guidelines and recommendations which will help ...

Thousands of men in the UK face unnecessary prostate cancer treatments. Current guidelines lag behind research. A study shows active monitoring is as effective as surgery or radiotherapy. Many men ...

NICE has published new draft recommendations to guide clinicians on the safe prescribing of medicines associated with dependence or withdrawal symptoms. The guideline focuses on benzodiazepines, ...

New draft guidelines from NICE to reduce the number of falls in those at risk could be challenging to implement because of a lack of resources, GPs have warned. The updated guidance now out for ...

The National Institute for Health and Care Excellence (NICE) has published new guidelines on the prevention and non-surgical management of pelvic floor dysfunction. The guideline is aimed at women – ...